Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the fiscal 2017 second quarter ended Dec. 31 of $33.1 billion, a 5 percent increase compared to the same period a year ago. Profit decreased 0.6 percent to $324 million.
Pharmaceutical segment sales increased 5 percent year-over-year to $29.7 billion. Segment profit decreased 14 percent to $537 million.
For the first six months, Cardinal Health reported sales of $65.2 billion, a 10 percent increase compared to the same period a year ago. Profit decreased 11 percent to $633 million.
